Incidence of pancreatitis with the use of immune checkpoint inhibitors (ICI) in advanced cancers: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence of pancreatitis with the use of immune checkpoint inhibitors (ICI) in advanced cancers: A systematic review and meta-analysis

Published:2019-06 Issue:4 Volume:19 Page:587-594
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

George John,Bajaj Divyansh,Sankaramangalam Kesavan,Yoo Jin Woo,Joshi Nikhil S.,Gettinger Scott,Price Christina,Farrell James J.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference46 articles.

1. Pembrolizumab versus chemotherapy for PD-L1–positive non–small-cell lung cancer;Reck;N Engl J Med,2016

2. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015

3. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N Engl J Med,2015

4. Immune-related adverse events associated with immune checkpoint blockade;Postow;N Engl J Med,2018

5. Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination;Boutros;Nat Rev Clin Oncol,2016

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitors in Cancer Treatment and Incidence of Pancreatitis;Cureus;2024-08-28

2. Incidence and Effect Duration of Immune Checkpoint Inhibitor-Related Pancreas Adverse Events;Pancreas;2024-08

3. Clinical characteristics and prognosis of pancreatitis associated with immune checkpoint inhibitors;Clinical and Translational Oncology;2024-07-12

4. Clinical characteristics, treatment and outcome of pembrolizumab-induced acute pancreatitis;Investigational New Drugs;2024-06-03

5. Pembrolizumab-Induced Pancreatitis: Take It With a Grain of Salt;Cureus;2024-04-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3